|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-26
|
|
pubmed:abstractText |
Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, has been shown to reduce the intestinal absorption of cholesterol. We investigated whether it also has beneficial effects on metabolic disorder and/or renal insufficiency in patients with hypercholesterolemia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/8-hydroxy-2'-deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Azetidines,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrates,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrites,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1880-3873
|
|
pubmed:author |
pubmed-author:AiharaKen-ichiK,
pubmed-author:AkaikeMasashiM,
pubmed-author:DagvasumberelMunkhbaatarM,
pubmed-author:HirataYoichiroY,
pubmed-author:IshikawaKazueK,
pubmed-author:IwaseTakashiT,
pubmed-author:KoshibaKunihikoK,
pubmed-author:KusunoseKenyaK,
pubmed-author:MatsumotoToshioT,
pubmed-author:NikiToshiyukiT,
pubmed-author:SataMasatakaM,
pubmed-author:SoekiTakeshiT,
pubmed-author:Sumitomo-UedaYukaY,
pubmed-author:TaketaniYoshioY,
pubmed-author:TomitaNorikoN,
pubmed-author:WakatsukiTetsuzoT,
pubmed-author:YagiShusukeS,
pubmed-author:YamadaHirotsuguH,
pubmed-author:YamaguchiKojiK,
pubmed-author:YoshidaSumikoS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
26
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-80
|
|
pubmed:meshHeading |
pubmed-meshheading:20150722-Aged,
pubmed-meshheading:20150722-Albuminuria,
pubmed-meshheading:20150722-Anticholesteremic Agents,
pubmed-meshheading:20150722-Azetidines,
pubmed-meshheading:20150722-C-Reactive Protein,
pubmed-meshheading:20150722-Case-Control Studies,
pubmed-meshheading:20150722-Cholesterol, LDL,
pubmed-meshheading:20150722-Deoxyguanosine,
pubmed-meshheading:20150722-Female,
pubmed-meshheading:20150722-Humans,
pubmed-meshheading:20150722-Hypercholesterolemia,
pubmed-meshheading:20150722-Male,
pubmed-meshheading:20150722-Metabolic Diseases,
pubmed-meshheading:20150722-Metabolic Syndrome X,
pubmed-meshheading:20150722-Middle Aged,
pubmed-meshheading:20150722-Nitrates,
pubmed-meshheading:20150722-Nitrites,
pubmed-meshheading:20150722-Oxidative Stress,
pubmed-meshheading:20150722-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan. syagi@clin.med.tokushima-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
